DE2657926C3 - Verfahren zur Bestimmung des Antistreptolysingehaltes im Blut - Google Patents
Verfahren zur Bestimmung des Antistreptolysingehaltes im BlutInfo
- Publication number
- DE2657926C3 DE2657926C3 DE2657926A DE2657926A DE2657926C3 DE 2657926 C3 DE2657926 C3 DE 2657926C3 DE 2657926 A DE2657926 A DE 2657926A DE 2657926 A DE2657926 A DE 2657926A DE 2657926 C3 DE2657926 C3 DE 2657926C3
- Authority
- DE
- Germany
- Prior art keywords
- solution
- red blood
- incubated
- blood
- solutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004369 blood Anatomy 0.000 title claims description 16
- 239000008280 blood Substances 0.000 title claims description 16
- 238000000034 method Methods 0.000 title claims description 14
- 210000003743 erythrocyte Anatomy 0.000 claims description 25
- 206010018910 Haemolysis Diseases 0.000 claims description 12
- 230000008588 hemolysis Effects 0.000 claims description 12
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 6
- 230000002949 hemolytic effect Effects 0.000 claims description 5
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 238000004062 sedimentation Methods 0.000 claims description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 3
- 235000010265 sodium sulphite Nutrition 0.000 claims description 3
- 150000003573 thiols Chemical class 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 2
- 239000004296 sodium metabisulphite Substances 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 238000012360 testing method Methods 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 4
- 102000006240 membrane receptors Human genes 0.000 description 4
- 108020004084 membrane receptors Proteins 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- BUDBHJPMAKXMLD-UHFFFAOYSA-N ethyl 6-methyl-2-phenylquinoline-4-carboxylate Chemical compound N=1C2=CC=C(C)C=C2C(C(=O)OCC)=CC=1C1=CC=CC=C1 BUDBHJPMAKXMLD-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
- G01N33/555—Red blood cell
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT09660/75A IT1155243B (it) | 1975-12-22 | 1975-12-22 | Attrezzatura per la titolazione degli anti corpi antistreptolisinici e metodo di titolazione con l impiego dei componenti di detta attrezzatura |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2657926A1 DE2657926A1 (de) | 1977-07-07 |
| DE2657926B2 DE2657926B2 (de) | 1978-06-08 |
| DE2657926C3 true DE2657926C3 (de) | 1979-02-08 |
Family
ID=11132951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2657926A Expired DE2657926C3 (de) | 1975-12-22 | 1976-12-21 | Verfahren zur Bestimmung des Antistreptolysingehaltes im Blut |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US4148609A (https=) |
| AR (1) | AR219288A1 (https=) |
| AT (1) | AT352903B (https=) |
| AU (1) | AU509644B2 (https=) |
| BE (1) | BE849754A (https=) |
| BR (1) | BR7608652A (https=) |
| CA (1) | CA1076025A (https=) |
| CH (1) | CH624772A5 (https=) |
| DE (1) | DE2657926C3 (https=) |
| DK (1) | DK145276C (https=) |
| ES (1) | ES454866A1 (https=) |
| FI (1) | FI60449C (https=) |
| FR (1) | FR2336685A1 (https=) |
| GB (1) | GB1531530A (https=) |
| GR (1) | GR59855B (https=) |
| IT (1) | IT1155243B (https=) |
| LU (1) | LU76434A1 (https=) |
| NL (1) | NL169787C (https=) |
| NO (1) | NO146581C (https=) |
| PT (1) | PT65994B (https=) |
| SE (1) | SE420953B (https=) |
| TR (1) | TR19262A (https=) |
| ZA (1) | ZA767051B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1132167B (it) * | 1980-07-03 | 1986-06-25 | Diesse Diagnostica Senese Srl | Metodo emolitico per la determinazione in continuo degli anticorpi antistreptolisina o,in campioni di sangue o di siero con impiego di streptolisina o ossidata |
| IT1218273B (it) * | 1981-05-07 | 1990-04-12 | Sclavo Inst Sieroterapeut | Metodo integrato per l'analisi degli anticorpi antistreptolisinici e mezzi adatti allo scopo |
| DE3210080A1 (de) * | 1982-03-19 | 1983-09-22 | Behringwerke Ag, 3550 Marburg | Anti-streptolysin o-latex-reagenz und verfahren zu seiner herstellung |
| US4554248A (en) * | 1982-11-08 | 1985-11-19 | American Home Products Corporation | Composition and method for detecting Antistreptolysin O |
| ES2037045T3 (es) * | 1986-09-24 | 1993-06-16 | Wako Pure Chemical Industries, Ltd. | Metodo nuevo para la determinacion del valor de antistreptolisina y un estuche utilizado para ello. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3789116A (en) * | 1970-12-09 | 1974-01-29 | Abbott Lab | Fluorescent labeled antibody reagent |
| US3925161A (en) * | 1973-07-18 | 1975-12-09 | Mary M Galvani | Fecal streptococci speciating media |
| US4038147A (en) * | 1976-06-15 | 1977-07-26 | Becton, Dickinson And Company | Method for detecting endotoxins |
-
1975
- 1975-12-21 TR TR19262A patent/TR19262A/xx unknown
- 1975-12-22 IT IT09660/75A patent/IT1155243B/it active
-
1976
- 1976-11-24 ZA ZA767051A patent/ZA767051B/xx unknown
- 1976-11-25 GR GR52267A patent/GR59855B/el unknown
- 1976-12-02 US US05/747,048 patent/US4148609A/en not_active Expired - Lifetime
- 1976-12-02 CA CA267,005A patent/CA1076025A/en not_active Expired
- 1976-12-03 AU AU20231/76A patent/AU509644B2/en not_active Expired
- 1976-12-07 GB GB51063/76A patent/GB1531530A/en not_active Expired
- 1976-12-17 CH CH1591976A patent/CH624772A5/it not_active IP Right Cessation
- 1976-12-17 ES ES454866A patent/ES454866A1/es not_active Expired
- 1976-12-20 PT PT65994A patent/PT65994B/pt unknown
- 1976-12-20 NL NLAANVRAGE7614167,A patent/NL169787C/xx active
- 1976-12-20 LU LU76434A patent/LU76434A1/xx unknown
- 1976-12-20 AR AR265936A patent/AR219288A1/es active
- 1976-12-20 NO NO764314A patent/NO146581C/no unknown
- 1976-12-20 FI FI763646A patent/FI60449C/fi not_active IP Right Cessation
- 1976-12-21 AT AT948876A patent/AT352903B/de not_active IP Right Cessation
- 1976-12-21 DE DE2657926A patent/DE2657926C3/de not_active Expired
- 1976-12-21 DK DK577376A patent/DK145276C/da active
- 1976-12-21 FR FR7638584A patent/FR2336685A1/fr active Granted
- 1976-12-21 SE SE7614389A patent/SE420953B/xx not_active IP Right Cessation
- 1976-12-22 BR BR7608652A patent/BR7608652A/pt unknown
- 1976-12-22 BE BE173554A patent/BE849754A/xx not_active IP Right Cessation
-
1981
- 1981-04-08 US US06/252,219 patent/USRE31372E/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69128618T2 (de) | Vorrichtung und verfahren zur ausführung von immunoassays | |
| DD157025A5 (de) | Verfahren fuer die ermittlung von haemoglobin im exkrement | |
| EP0292810A2 (de) | Einschritt-Immuntest zur Bestimmung von antigen-spezifischen Antikörpern aus einer der Immunglobulin-Klassen A, M, D oder E und dazu geeignetes Mittel | |
| DE2602997C2 (de) | Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung | |
| DE2711288A1 (de) | Antigen-membran fuer die anwendung bei der diagnose der syphilis und vorrichtung fuer die syphilis-diagnose | |
| EP0077515B1 (de) | Verfahren und Reagenz zur Bestimmung von glykosiliertem Hämoglobin | |
| DE69030480T2 (de) | Verfahren und Vorrichtung zum Nachweis sensibilisierter Leukozyten | |
| DE1773363A1 (de) | Verfahren und Produkt zum Pruefen des Vorhandenseins von Haemoglobin S | |
| DE2657926C3 (de) | Verfahren zur Bestimmung des Antistreptolysingehaltes im Blut | |
| DE3105555A1 (de) | Reagens zum nachweis des rheumatoidfaktors, verfahren zu seiner herstellung und seine verwendung | |
| DE2163318C3 (de) | Verfahren zur Herstellung von zur passiven Agglutination geeigneten Tra gerteilchen aus mit Formaldehyd be handelten Mikroorganismen | |
| DE2037507A1 (https=) | ||
| EP1386160B1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| EP0571939B1 (de) | Mittel zur Bestimmung eines Analyts | |
| DE69013730T2 (de) | Für ganze Zellen geeigneter Satz und Verfahren zu enzymatischen Bestimmungen. | |
| DE2054805C3 (de) | Indirekter Hämagglutinationstest bei gleichzeitiger Absorption heterologer Antikörper | |
| DE2533701A1 (de) | Immunologische diagnoseprodukte | |
| DE1617734B1 (de) | Verfahren zur Herstellung eines immunologischen Reagens | |
| DE2840847A1 (de) | Verfahren zum nachweis und zur bestimmung komplementbindender antikoerper | |
| DE2725594C2 (de) | Verfahren zur Bestimmung der Konzentration freier Schilddrüsenhormone in Flüssigkeiten, insbesondere Blutseren | |
| EP0291843B1 (de) | Testkit zur Bestimmung eines Analyten im Stuhl | |
| DE69332100T2 (de) | Verfahren und vorrichtung zum nachweis von zellen | |
| DE69922213T2 (de) | Verfahren und testsatz zur bestimmung der analytkonzentration im blut | |
| DE68925387T2 (de) | Verfahren zur Behandlung von Immunotest-Proben, die Schleim enthalten | |
| CH636448A5 (en) | Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8339 | Ceased/non-payment of the annual fee |